From roadmap to a sustainable end-to-end individualized therapy pathway. - Jonker AH; Tataru EA; Dimmock DP; Bateman-House A; Graessner H; Baynam G; Augustine EF; Jaffe A; Pasmooij AMG; Iliach O; Horgan R; Davies J; et al. (Therapeutic advances in rare disease, 2025)